title: [Clinical course of congenital toxoplasmosis in children].
abstract: Hundred eleven children with the congenital toxoplasmosis were treated at the Department of Infectious and Parasitic Diseases in Childhood in 1979-1988. Multi-symptomatic toxoplasmosis has been diagnosed in 35 cases, ocular form in 65, oligosymptomatic in 6, and asymptomatic in 5 cases. Clinical symptoms suggesting congenital toxoplasmosis was seen in the majority of children (63 cases) in the first year of life and the disease was diagnosed in 50% of cases (33 children) at this age. Congenital toxoplasmosis in the group of 78 children has been diagnosed later. The majority of cases was ocular form. Diagnosis of the oligo- and asymptomatic congenital toxoplasmosis is possible in the first year of life, only. A titre of antibodies is exclusively an indicator of the immunologic response, not a severity of infection and does not contribute to the prognosis. Antitoxoplasma drugs were administered to 102 children including 33 under the first year of life. Pyrimethamine, sulphonamides, and spiramycin were used in the treatment. Dosage, duration of therapy, and way of administration have been established individually in dependence of patients age and clinical form of the congenital toxoplasmosis. Two out of 35 children with multi-symptomatic congenital toxoplasmosis died whereas 13 demonstrate psychomotor retardation of significant degree despite the fact that 11 of them were treated in the first year of life.
authors.affiliation: Kliniki Chorób Zakaźnych i Pasozytniczych Wieku Dzieciecego AM, Warszawie.
authors.forename: H
authors.initials: H
authors.lastname: Jankowska
authors.forename: M
authors.initials: M
authors.lastname: Szczepańska-Putz
mesh_terms: D000293:Adolescent; D000367:Age Factors; D000818:Animals; D000913:Antibodies, Protozoan / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D002825:Chorioretinitis / Q000151:congenital* / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D003049:Coccidiostats / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D014122:Toxoplasma / Q000276:immunology*; D014125:Toxoplasmosis, Congenital / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D014126:Toxoplasmosis, Ocular / Q000151:congenital* / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology
chemical_list: D000913:Antibodies, Protozoan; D003049:Coccidiostats
vernacular_title: Przebieg kliniczny toksoplazmozy wrodzonej u dzieci.